Cadence Bank’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-7,000
Closed -$375K 198
2020
Q4
$375K Buy
+7,000
New +$363K 0.06% 161
2019
Q3
Sell
-54,568
Closed -$2.57M 226
2019
Q2
$2.57M Buy
54,568
+4,133
+8% +$191K 0.25% 66
2019
Q1
$2.43M Buy
50,435
+1,149
+2% +$57.6K 0.24% 68
2018
Q4
$2.2M Buy
49,286
+1,761
+4% +$91.8K 0.26% 66
2018
Q3
$2.57M Buy
47,525
+708
+2% +$36.2K 0.24% 63
2018
Q2
$2.29M Buy
+46,817
New +$2.65M 0.21% 69
2018
Q1
Sell
-33,819
Closed -$2.07M 244
2017
Q4
$2.07M Buy
+33,819
New +$2.09M 0.2% 75

Other funds holding CAH

Cadence Bank's CAH Position: Q1 2021 in Review

Cadence Bank sold out of Cardinal Health (CAH) in Q1 2021, closing a stake of 7,000 shares — an estimated $375K sold.

Cadence Bank first reported a position in CAH in Q4 2017 and held it in 7 quarters. The position peaked at $2.57M in Q2 2019. 802 funds tracked by Wall St. Rank hold CAH as of Q1 2021.

  • Cadence Bank reported no remaining Cardinal Health position as of Q1 2021 after selling out during the quarter.
  • Cadence Bank sold 7,000 Cardinal Health shares in Q1 2021, an estimated $375K.
  • Cadence Bank first reported a position in Cardinal Health in Q4 2017 and held it in 7 quarters.
  • Cadence Bank's Cardinal Health position peaked at $2.57M in Q2 2019.
  • 802 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2021.

Based on Cadence Bank's 13F filing for Q1 2021, filed 11 May 2021.